International Conference on Vaccines Research & Development is a federally registered trademark (reg.no. 5226683) owned by USG United Scientific Group (A non-profit organization). Beware of fraudulent conferences mimicking the Official Vaccines R&D Conference.
Conference Overview
The Vaccines R&D 2025 conference is set to serve as a dynamic platform, fostering interdisciplinary collaboration at the cutting edge of accelerated and essential vaccine research. Across a span of three days, distinguished speakers from around the world, representing industry, academia, federal bodies, and regulatory agencies, will share groundbreaking advancements, address contemporary challenges, and provide inspirational insights and innovative lessons gained during the vaccine development process.
More InfoWhy Choose Us!
Director, CBER, U.S. Food and Drug Administration
Chief Executive and Scientific Officer, Sanaria Inc.
Chief Research and Development Officer, InDevR
CEO and Chief Scientific Officer, Fina Biosolutions
The conference explores a wide range of topics and sessions, delving into the following areas:
mRNA, Vector-based, Nanoparticle vaccines, Adjuvants and Emerging technologies
RSV, Influenza, COVID-19, Pneumococcal, Tuberculosis, Whooping cough
Preclinical studies, Clinical trials, Regulatory review, Manufacturing, Quality control, Post-market surveillance
Antibody production, Neutralization assays, Immune markers, Cytokine profiles, mAbs
Zika, Ebola, Marburg, Lassa fever, Dengue
DTP, Pneumococcal, Meningococcal, MMR, Hepatitis, HPV, Chickenpox
Recombinant, Polysaccharide, Subunit vaccines
Antigen production, Formulation, QC, Scale-Up, Cold Chain management
Immune response, Duration of protection, Vaccine efficacy, Subunit vaccines
Preventive, Therapeutic vaccines, Tumor antigens
Preclinical testing, Adverse event reporting, Regulatory approval, Vaccine hesitancy
Phase I, II and III studies
For the individuals
For the individuals
For the individuals
For the individuals
Thank you for organizing a great conference, great speakers and many expertise! Great job!! It is my first time attend VRD and I have spread it around to encourage my colleagues to attend in future.
It was an excellent meeting. I would suggest that a little more time be left for interaction with other participants between the formal sessions at the coffee breaks.
I was a novice at this meeting and I liked the program and the interactions. An excellent venue, nice rooms, good breakfast, fantastic lunch, great coffee breaks and impeccable technical conductance.
The meeting was great, gained new knowledge and new friends. For sure I will try to come back again.
I'm very happy that I had the opportunity to attend Vaccines R&D 2022 Conference in Boston, MA, which exposed me to an international group of experts in the vaccine field. It was just the right size of a group where we could network, share ideas, and get to know each other in person to a great extent.
I truly enjoyed being part of the conference, which was very interesting and divers. I must also say that it was very well run and a pleasure to be part of it.
It was really a great meeting this year, with an impressive roster of speakers the day I attended.
Congratulations. You have really made progress, and the meeting is getting better each time.
Thank you, I learned much at this meeting and made many new contacts.
The meeting is getting better every year. Great work in organizing the speaker line.
It's hard to put on a good conference. United Scientific Group did a great job with Vaccines R&D 2022 Boston. In addition, to an excellent line-up of speakers, they were (almost) ruthless in holding speakers to their allotted time. For me, having the opportunity to meet with a small group of conjugate vaccine scientists was terrific.
